Physician profile
Christopher Miskovsky
NPI 1093710816
$31,418.84
in general payments reported to CMS, 2019-2025
23 companies · $18K in 2025
The $18K reported for 2025 was more than what 95% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $616 · 2020: $1,099 · 2021: $1,294 · 2022: $1,405 · 2023: $2,310 · 2024: $6,968 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $4,538 · Food and Beverage: $3,498 · Education: $319 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,575.25 |
| Travel and Lodging | $4,538.03 |
| Food and Beverage | $3,498.19 |
| Education | $318.90 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $19,502.69 | 2020-2025 | Arthrex |
| Medartis INC. | $6,242.57 | 2025 | Aptus |
| Pylant Medical | $4,489.95 | 2019-2025 | |
| Depuy Synthes Sales INC. | $157.07 | 2021-2025 | Na, Monovisc, Orthovisc |
| Amgen INC. | $146.21 | 2025 | Evenity |
| Kerecis Limited | $143.81 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Integra Lifesciences Corporation | $142.34 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $114.37 | 2019-2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $87.14 | 2025 | |
| Sanofi-Aventis U.S. LLC | $84.04 | 2021-2023 | |
| Trimed, INC. | $47.95 | 2025 | |
| Acumed LLC | $32.76 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $30.07 | 2023 | Seglentis |
| Axogen | $25.28 | 2023 | Avance Nerve Graft |
| Stryker Corporation | $23.47 | 2025 | Variax, Conextions Tr Tendon Repair System-Implant Mechanism, Asnis |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $22.77 | 2019 | |
| Biocircuit Technologies INC | $21.89 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $20.20 | 2023 | Caldolor |
| Sonex Health, INC. | $18.84 | 2023 | Sx-One Microknife |
| Avanos Medical | $18.66 | 2023 | Trivisc Sodium Hyaluronate |
| Pacira Therapeutics, INC. | $17.66 | 2019 | |
| Bioventus LLC | $15.75 | 2019 | |
| Abbott Laboratories | $13.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Miskovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.